Startseite

Aktien

iRhythm Technologies

Nachrichten

iRhythm Technologies Aktie

Aktie

ISIN: US4500561067 WKN: A2ATTS SYM: I25 Land Flagge US

USA

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

145,00

EUR

-6,45 %

-10,00 EUR

Letzter Kurs 13.11.25 Tradegate

iRhythm Technologies Aktie kaufen

Geldkurs

15:22:51

142,00

EUR

71 STK

Briefkurs

15:22:51

145,00

EUR

69 STK

Verkauf

Kauf

Hinweis
Verlängerte Handelszeiten
Ab sofort von 07:30 bis 23:00 Uhr

Neueste Nachrichten

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of iRhythm Technologies, Inc. – IRTC 13.11.25 · Business Wire (engl.) · iRhythm Technologies
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm 12.11.25 · newsfile · iRhythm Technologies
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of iRhythm Technologies, Inc. – IRTC 11.11.25 · Business Wire (engl.) · iRhythm Technologies
iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025 11.11.25 · globenewswire · iRhythm Technologies
iRhythm Technologies to Participate in Upcoming Investor Conferences 04.11.25 · globenewswire · iRhythm Technologies
iRhythm Technologies Announces Third Quarter 2025 Financial Results 30.10.25 · globenewswire · iRhythm Technologies
Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights 23.10.25 · Business Wire (engl.) · iRhythm Technologies
iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025 16.10.25 · globenewswire · iRhythm Technologies
AI in Remote Patient Monitoring Market Projected to Reach US$ 10.35 Billion by 2033, Expanding at 6.7% CAGR, According to DataM Intelligence 18.09.25 · PR Newswire (engl.) · Abbott Laboratories
Sensor Patch Market worth $23.91 billion by 2030 - Exclusive Report by MarketsandMarkets 06.09.25 · PR Newswire (engl.) · Abbott Laboratories
AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies’ Zio LTCM Service 29.08.25 · globenewswire · iRhythm Technologies
iRhythm Technologies to Participate in Upcoming Investor Conferences 20.08.25 · globenewswire · iRhythm Technologies

1
2
3
…
4

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and ... 112 Leser

iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data ... 144 Leser
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and ... 116 Leser
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and ... 112 Leser
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm 104 Leser

iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data ... 144 Leser
iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025 132 Leser
Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss ... 132 Leser
iRhythm Technologies Announces Third Quarter 2025 Financial Results 124 Leser
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and ... 116 Leser
iRhythm Technologies to Participate in Upcoming Investor Conferences 112 Leser
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and ... 112 Leser
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm 104 Leser

DAX, Workiva Registered (A) & Co. – Tops & Flops der Community am Nachmittag 1472 Leser
Insider-Trades: Directors' Dealings – Die wichtigsten Transaktionen - KW 33/25 1120 Leser
Insider-Trades: Directors' Dealings – Die wichtigsten Transaktionen - KW 26/25 1000 Leser
iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of ... 160 Leser
iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce ... 156 Leser
Sensor Patch Market worth $23.91 billion by 2030 - Exclusive Report by MarketsandMarkets 148 Leser
New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in ... 144 Leser
iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data ... 144 Leser
iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio Long-Term ... 144 Leser
AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm’s Zio LTCM Clinical ... 136 Leser